Posterior leukoencephalopathy syndrome in children and adolescents

Journal of Child Neurology

Volumn 22, Issue 4, 2007, Pages 406-413

  Alehan, Füsun ^a   Erol, Ilknur ^a   Agildere, Muhtesem A ^a   Ozcay, Figen ^a   Baskin, Esra ^a   Cengiz, Nurcan ^a   Alioglu, Bülent ^a   Haberal, Mehmet ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Children and adolescents; Neuroimaging; Posterior leukoencephalopathy syndrome

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ABDUCENS NERVE PARALYSIS; ADOLESCENT; APLASTIC ANEMIA; ARTICLE; BRAIN DISEASE; CEREBRAL BLINDNESS; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONSCIOUSNESS DISORDER; DIAGNOSTIC IMAGING; DIASTOLIC BLOOD PRESSURE; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; FOCAL EPILEPSY; FOLLOW UP; GRAND MAL SEIZURE; HEADACHE; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; LETHARGY; LEUKOENCEPHALOPATHY; LIVER GRAFT REJECTION; MALE; NEUROIMAGING; OCCIPITAL LOBE; PARIETAL LOBE; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; RADIODIAGNOSIS; SEIZURE; SIDE EFFECT; STUPOR; SYMPTOM; SYSTOLIC BLOOD PRESSURE; TONIC CLONIC SEIZURE; UREMIA;

ADOLESCENT; BLINDNESS; BRAIN DISEASES; CEREBRAL CORTEX; CHILD; CHILD, PRESCHOOL; FEMALE; HEADACHE; HUMANS; HYPERTENSION, RENAL; IMMUNOSUPPRESSIVE AGENTS; INORGANIC CHEMICALS; KIDNEY FAILURE; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; SEIZURES; SYNDROME; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34250371323     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073807301932     Document Type: Article

References (27)

1. Hinchey J., Chaves C., Appignani B., et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334:494-500.
2. Kwon S., Koo J., Lee S. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol. 2001;24:361-364.
3. Garg RK Posterior leukoencephalopathy syndrome Postgrad Med J. 2001;77:24-28.
4. Pavlakis SG, Frank Y., Kalina P., et al. Occipital-parietal encephalopathy: A new name for an old syndrome. Pediatr Neurol. 1997;16:145-148.
5. Delanty N., Vaughan C., Frucht S., Stubgen P. Erythropoietin associated hypertensive posterior leukoencephalopathy. Neurology. 1997;49:686-689.
6. Taylor MB, Jackson A., Weller JM Dynamic susceptibility contrast enhanced MRI in reversible posterior leukoencephalopathy syndrome associated hemolytic uremic syndrome. Br J Radiol. 2000;73:438-442.
7. Mathy I., Gille M., Van Raemdonck F, et al. Neurological complications of intravenous immunoglobulin (IVIg) therapy: An illustrative case of acute encephalopathy following IVIg therapy and a review of the literature. Acta Neurol Belg. 1998;98:347-351.
8. Ito Y., Niwa H., Lida T., et al: Post-transfusion reversible posterior leukoencephalopathy syndrome with cerebral vasoconstriction. Neurology. 1997;49:1174-1175.
9. Froehlich T., Sandifer S., Varma PK, Testa FM Two cases of hypertension-induced reversible posterior leukoencephalopathy syndrome secondary to glomerulonephritis. Curr Opin Pediatr. 1999;11:512-518.
10. Ayus J., Wheeler J., Arieff A. Postoperative hyponatremic encephalopathy in menstruant women. Ann Intern Med. 1992;117:891-897.
11. Singh N., Bonham A., Fukui M. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. Transplantation. 2000;69:467-472.
12. Gijtenbeek JM, van den Bent MJ, Vecht CJ Cyclosporine neurotoxicity: A review. J Neurol. 1999;246:339-346.
13. Nakamura M., Fuchinoue S., Sato S., et al. Clinical and radiological features of two cases of tacrolimus-related posterior leukoencephalopathy in living related liver transplantation. Transplant Proc. 1998;30:1477-1478.
14. Small S., Fukui M., Bramblett G., Eidelman B. Immunosuppression-induced leukoencephalopathy from tacrolimus. Ann Neurol. 1999;40:575-572.
15. Bonham CA, Dominguez EA, Fukui MB, et al. Central nervous system lesions in liver transplant recipients: Prospective assessment of indications for biopsy and implications for management. Transplantation. 1998;66:1596-1604.
16. Parvex P., Pinsk M., Bell LE, et al. Reversible encephalopathy associated with tacrolimus in pediatric renal transplants. Pediatr Nephrol. 2001;16:537-542.
17. Schwartz RB, Bravo S., Kuflas R., et al. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MRI findings in 16 cases. AJR Am J Roentgenol. 1995;156:627-631.
18. Kochi S., Takanaga H., Matsuo H., et al. Effect of cyclosporine A or tacrolimus on the function of blood-brain barrier cells. Eur J Pharmacol. 1999;372:287-295.
19. Prasad N., Gulati S., Gupta RK, et al. Is reversible posterior leucoencephalopathy with severe hypertension completely reversible in all patients. Pediatr Nephrol. 2003;18:1161-1166.
20. Phal P., Molan M., Clare I. Hypertensive encephalopathy. Australas Radiol. 2002;46:319-324.
21. Mukherjee P., McKinstry RC Reversible posterior leukoencephalopathy syndrome: Evaluation with diffusion tensor MR imaging. Radiology. 2001;219:756-765.
22. Covarrubias DJ, Luetmer PH, Campeau NG Posterior reversible encephalopathy syndrome: Prognostic utility of quantitative diffusion-weighted MR images. Am J Neuroradiol. 2002;23:1038-1048.
23. Pavlakis SG, Frank Y., Chusid R. Hypertensive encephalopathy, reversible occipitoparietal encephalopathy, or reversible posterior leukoencephalopathy: Three names for an old syndrome. J Child Neurol. 1999;14:277-281.
24. Kinoshita T., Moritani T., Shrier DA, et al. Diffusion-weighted MR imaging of posterior reversible leukoencephalopathy syndrome: A pictorial essay. Clin Imaging. 2003;27:307-315.
25. Ay H., Buonanno FS, Schaefer PW, et al. Posterior leukoencephalopathy without severe hypertension: Utility of diffusion weighted MRI. Neurology. 1998;51:1369-1376.
26. Schwartz RB, Jones KM, Kalina P., et al. Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases. AJR Am J Roentgenol. 1992;159:379-383.
27. Antunes NL, Small TN, George D., Boulad F., et al. Posterior leukoencephalopathy syndrome may not be reversible. Pediatr Neurol. 1999;20:241-243.